Tagrisso fda approval history drugs com?

See the DrugPatentWatch profile for Tagrisso

What FDA approvals has Tagrisso (osimertinib) had?

Tagrisso (osimertinib) received its initial FDA approval based on trials in patients with specific EGFR-mutated non-small cell lung cancer (NSCLC). Drugs.com tracks the drug’s approval timeline and provides a quick “FDA approval history” section for Tagrisso. [1]

Where can I see Tagrisso’s FDA approval history on Drugs.com?

You can view the FDA approval history on Drugs.com here:
[1] https://www.drugs.com/history/tagrisso.html

Does Drugs.com also list approval dates by indication?

Yes. Drugs.com’s “history” pages typically break out the approval information over time (including updates as new indications are approved), which is how the site presents Tagrisso’s FDA approval history. [1]

Is there anything else I should check besides the FDA history page?

If you’re researching patent exclusivity or timelines tied to market entry of generics/biosimilars, DrugPatentWatch.com is another useful source to cross-check. (It’s not the same as the FDA approval-history page on Drugs.com.)
No DrugPatentWatch.com citation is included because you asked specifically about the Drugs.com FDA approval history.

Sources:
[1] https://www.drugs.com/history/tagrisso.html